COMMUNIQUÉS West-GlobeNewswire

Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:02

SAN CARLOS, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, [...]

TerrAscend Enters Ohio with the Signing of Definitive Agreement to Acquire a Well Situated and Profitable Dispensary

06/11/2024 - 22:02

Acquisition represents the Company’s initial entry into its sixth state ; Intends to be a leader in Ohio through additional acquisitions Expected to be immediately accretive on an EBITDA and cashflow basis TORONTO, Nov [...]

Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress

06/11/2024 - 22:02

Phase 3 pivotal trial underway evaluating RMC-6236 in patients with metastatic pancreatic ductal adenocarcinoma (PDAC), supported by compelling clinical profile First clinical results for RMC-9805, a RAS(ON) G12D- [...]

Health Catalyst Reports Third Quarter 2024 Results

06/11/2024 - 22:03

SALT LAKE CITY, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported [...]

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

06/11/2024 - 22:03

Collaboration enhances unprecedented access to deep, unbiased proteomics at scale, enabling deeper insights into human biology REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading [...]

Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Troisième Trimestre 2024

06/11/2024 - 22:05

INFORMATIONS RÉGLEMENTÉES N yxoah Présente ses Résultats Financiers et d’Exploitation pour le Troisième Trimestre 2024 L'approbation de la FDA est en bonne voie pour le premier trimestre 2025, l'équipe commerciale [...]

Nyxoah Reports Third Quarter Financial and Operating Results

06/11/2024 - 22:05

REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating Results FDA approval on track for first quarter 2025 , U.S. commercial team build out in progress Company fully funded with cash until mid 2026 [...]

MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

06/11/2024 - 22:05

ROCKVILLE, MD, November 6, 2024 — MaxCyte, Inc. (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and [...]

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:05

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results

06/11/2024 - 22:05

Non-human primate data presented at ESGCT demonstrated selective in vivo delivery of mRNA with T cell-targeted lipid nanoparticle (ctLNP) Cash balance of $199.8 million expected to fund operations into 2H 2027 CAMBRIDGE [...]

Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership

06/11/2024 - 22:05

Delivers 9% Total Revenue growth year-to-date compared to prior year period Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA [...]

Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences

06/11/2024 - 22:05

FOSTER CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]

Option Care Health to Participate in Upcoming Investor Conferences

06/11/2024 - 22:05

BANNOCKBURN, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will [...]

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

06/11/2024 - 22:05

IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat [...]

Emergent BioSolutions Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:05

Third Quarter 2024 Total Revenues of $293.8 million, increase of 9% versus prior year Third Quarter 2024 Net Income of $114.8 million, increase of 144% versus prior year Third Quarter 2024 Adjusted EBITDA of $105.3 [...]

Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

06/11/2024 - 22:05

Presented interim data from the ongoing Phase 1 dose escalation study of PRT3789, its first-in-class IV SMARCA2 degrader, demonstrating clinical proof of concept Initiated a Phase 1 trial for PRT7732, its first-in-class [...]

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook

06/11/2024 - 22:05

Q3 2024: Net sales of $502 million (+5% actual rates, +6% constant exchange rates, CER); diluted EPS of $0.44 and adjusted diluted EPS of $0.57 // Net sales of $502 million CER ahead of outlook for at least $495 million [...]

Inari Medical to Participate in the Jefferies London Healthcare Conference

06/11/2024 - 22:05

IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]

Seer Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:05

Growing enthusiasm for Proteograph Product Suite with multiple larger orders from government agencies and continued strong interest in STAC REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: [...]